Serological Correlate of Protection Established by Neutralizing Antibodies Differs Among Dialysis Patients with SARS-CoV-2 Variants of Concern
Open Access
Abstract
Background: The 2019 coronavirus disease (COVID-19) pandemic had a severe impact on frail, end-stage kidney disease (ESKD) patients, either on dialysis or transplanted, with a high mortality rate in the early waves. Vaccination against SARS-CoV-2 with mRNA vaccines has led to reduced hospitalization and mortality rates in the general population and ESKD patients. Neutralizing antibodies (NAbs) are a valuable correlate of protection after vaccination, and IgG anti-spike antibodies are considered a surrogate marker of protection. Methods: This study investigated the correlates of protection brought by NAb and anti-spike IgG antibodies against SARS-CoV-2 wild-type Wuhan strain and variants of concern in a cohort of 128 French patients on dialysis after vaccination with the BNT162b2 mRNA vaccine. The correlate was assessed using Receiver Operating Characteristic curves. Results: The level of protection for IgG anti-spike antibodies was set at 917 BAU/mL for the original Wuhan strain and 980 BAU/mL and 1450 BAU/mL, respectively, for the Delta and Omicron BA.1 variants. Conclusions: The level of protection can be regularly monitored by measuring IgG anti-spike antibody concentrations to allow tailored boosters of SARS-CoV-2 vaccination in this frail and immunocompromised ESKD population.Keywords
Funding Information
- Ramsay Health Cooperation Group for Education and Research (COS-RGDS-2021-06-075)
- Nexelis/Q2 Solutions (COS-RGDS-2021-06-075)
- Newmed Publishing (COS-RGDS-2021-06-075)
- StatEthic (COS-RGDS-2021-06-075)
This publication has 17 references indexed in Scilit:
- mRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infectionJournal Of Nephrology, 2024
- Long-Term Neutralizing Antibody Titers After BNT162b2 Vaccination in Hemodialysis PatientsKidney International Reports, 2023
- Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infectionNature Communications, 2023
- Evaluation of SARS‐CoV‐2 antibody levels on hospital admission as a correlate of protection against mortalityJournal of Internal Medicine, 2023
- A Covid-19 Milestone Attained — A Correlate of Protection for VaccinesNew England Journal of Medicine, 2022
- Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyJournal of Infection, 2022
- Covid-19 Vaccines — Immunity, Variants, BoostersNew England Journal of Medicine, 2022
- COVID-19 in dialysis: clinical impact, immune response, prevention, and treatmentKidney International, 2022
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assaysNature Protocols, 2021